Abstract
Purpose of Review
The purpose of this review is to summarize the recently published evidence concerning vertebral fracture risk in individuals with diabetes mellitus.
Recent Findings
Vertebral fracture risk is increased in individuals with T2DM. The presence of vertebral fractures in T2DM is associated with increased non-vertebral fracture risk and mortality. TBS could be helpful to estimate vertebral fracture risk in individuals with T2DM. An increased amount of bone marrow fat has been implicated in bone fragility in T2DM. Results from two recent studies show that both teriparatide and denosumab are effective in reducing vertebral fracture risk also in individuals with T2DM.
Summary
Individuals with T2DM could benefit from systematic screening in the clinic for presence of vertebral fractures.
Ex Vivo and In Vivo Assessment of Vertebral Strength and Vertebral Fracture Risk Assessed by Dual Energy X-Ray Absorptiometry